Discontinued — last reported Q4 '24
DexCom Products & Services — Inventory write-down remained flat by 0.0% to $13.38M in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 222.3%, from $4.15M to $13.38M. Over 3 years (FY 2021 to FY 2024), Products & Services — Inventory write-down shows an upward trend with a 23.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests potential overstocking, product obsolescence, or declining demand for the specific hardware component, while a decrease indicates effective inventory turnover and product lifecycle management.
This metric represents the expense recognized when the carrying value of inventory associated with receiver product comp...
Comparable to inventory obsolescence charges or inventory valuation adjustments reported by medical device manufacturers transitioning from standalone hardware to integrated digital ecosystems.
dxcm_segment_receiver_product_component_inventory_write_down| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.03M | $7.03M | $7.03M | $3.48M | $3.48M | $3.48M | $3.48M | $4.15M | $4.15M | $4.15M | $4.15M | $13.38M | $13.38M | $13.38M | $13.38M |
| QoQ Change | — | +0.0% | +0.0% | -50.5% | +0.0% | +0.0% | +0.0% | +19.4% | +0.0% | +0.0% | +0.0% | +222.3% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -50.5% | -50.5% | -50.5% | +19.4% | +19.4% | +19.4% | +19.4% | +222.3% | +222.3% | +222.3% | +222.3% |